SEC Tracker
Get the app

Alx Oncology Holdings ALXO

ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer

Form
8-K
Filed
Importance
Routine
  • Reports an executive or board change (5.02)
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Alx Oncology Holdings files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Charlie's Holdings CHUC public float $18M, Jun 30, 2025
  2. Cognition Therapeutics CGTX public float $18M, Jun 30, 2025
  3. IGC Pharma IGC public float $18M, Jun 30, 2025
  4. Ernexa Therapeutics ERNA public float $18M, Jun 30, 2025
  5. Marker Therapeutics MRKR public float $17M, Jun 30, 2025